facs permeabilizing solution2 1x (Becton Dickinson)
90
Structured Review
Becton Dickinson
facs permeabilizing solution2 1x
Facs Permeabilizing Solution2 1x, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/permeabilizing-solution2/facs+permeabilizing+solution/pmc09467550-87-14-20
Average 90 stars, based on 1 article reviews
Facs Permeabilizing Solution2 1x, supplied by Becton Dickinson, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/permeabilizing-solution2/facs+permeabilizing+solution/pmc09467550-87-14-20
Average 90 stars, based on 1 article reviews
facs permeabilizing solution2 1x - by Bioz Stars,
2026-09
90/100 stars
Images
Related Articles
FACS:Article Title: Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferons Article Snippet: Briefly, cells were incubated with LIVE/DEAD Fixable Green Dead Cell Stain Kit (ThermoFischer Scientific) and fluorochrome-conjugated antibodies directed against surface markers ( ) for 20 min at room temperature in the dark followed by 2 washes with flow cytometry buffer (PBS with 2 mM EDTA). .. Cells were then fixed and permeabilized using FACS Lysing solution and Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: Cells were then washed with PBS and stained with Live/Dead Fixable Blue Dead Cell Stain Kit (Invitrogen #L23105) according to the manufacturer’s instructions, washed with FACS buffer and incubated with 1:25 dilution anti-CD16 (BioLegend #302036) and 1:50 anti-CD20 (BD #563126) antibodies per sample. .. Cells were then washed twice, and residual red blood cells were lysed and all cells fixed in 100 ml BD lysis buffer (BD #349202), washed, and incubated with 200 ml BD Article Title: NKp30 and NKG2D contribute to natural killer recognition of HIV-infected cells Article Snippet: .. For the samples that require intracellular staining, cells were subsequently fixed with FACS Lyse (BD Biosciences), permeabilized with Article Title: IL-10 indirectly modulates functional activity of CD4 + CD28 null T-lymphocytes through LFA-3 and HLA class II inhibition. Article Snippet: Immunology Department, Hospital Universitario Central de Asturias, Oviedo, Spain Instituto de Investigaci on Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain Section of Hemodynamics and Interventional Cardiology, Department of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Recombinant AMMO1 Snijder et al.28 N/A Recombinant CL40 with human constant regions Singh et al.30 N/A Recombinant CL59 with human constant regions Singh et al.30 N/A Recombinant 72A1 with human constant regions Singh et al.30 N/A Recombinant E1D1 with human constant regions Malhi et al.38 N/A Recombinant 770F7 Chen et al.27 N/A Recombinant 1D8 Zhu et al.29 N/A Recombinant 769B10 Bu et al.26 N/A AF488 anti-human CD3 clone SP34-2 BD Biosciences Cat#557705; RRID:AB_396814 AF488 anti-human CD4 clone OKT4 Biolegend Cat#317419; RRID:AB_571938 AF488 anti-human CD8 clone RPA-T8 BD Biosciences Cat#557704; RRID:AB_396813 AF488 anti-human CD14 clone M5E2 BD Biosciences Cat#561706; RRID: AB_10924601 BV421 anti-human CD20 clone 2H7 Biolegend Cat#302329; RRID: AB_10933088 anti-human CD28/ anti-CD49d BD Biosciences Cat#347690; RRID:AB_647457 BV570 anti-human CD16 Biolegend Cat#302036; RRID:AB_2632790 BV711 anti-human CD20 BD Biosciences Cat#563126; RRID:AB_2313579 BUV805 anti-human CD8 BD Biosciences Cat#612889; RRID:AB_2833078 BV480 anti-human CD4 BD Biosciences Cat#566148; RRID:AB_2739546 BUV395 anti-human CD3 BD Biosciences Cat#564117; RRID:AB_2738603 BB515 anti-human TNFa ThermoFisher Cat#11-7349-82; RRID: AB_465424 BV421 anti-human IFN-g BD Biosciences Cat#560371; RRID:AB_1645594 Allophycocyanin (APC)-anti-human IL-2 BioLegend Cat#500310; RRID:AB_315097 Goat anti-human IgG-HRP Southern Biotech Cat#2010-05; RRID:AB_2795564 Goat anti-human IgG Southern Biotech Cat#2040-01; RRID:AB_2795640 Bacterial and virus strains EBV B95.8/F Delecluse et al.53 N/A Rhesus Lymphocryptovirus strain LCL 8664 ATCC Cat#CRL-1805; RRID: CVCL_3464 Biological samples Rhesus macaque blood Washington National Primate Research Center N/A Chemicals, peptides, and recombinant proteins Sigma Adjuvant Systems Sigma Aldrich Cat#S6322 SMNP Silva et al.40 N/A NeutrAvidin Thermofisher Cat#31000 SureBlue Reserve TMB Microwell Peroxidase substrate SeraCare Cat#5120-0081 Totalseq APC-streptavidin BioLegend Cat#405283 Phycoerythrin (PE)- streptavidin BioLegend Cat#405203 eFluor 506 viability dye eBioscience Cat#65-0866-14 Rhesus Fc receptor inhibitor eBioscience Cat#14-9161-73 Overlapping 15 amino acid peptide pools spanning EBV gH and gL This study Synthesized by Mimotopes Brefeldin A Sigma-Aldrich Cat#B-7651 Live/Dead Fixable Blue Dead Cell Stain Kit Invitrogen Cat#L23105 BD lysis buffer BD Biosciences Cat#349202 (Continued on next page) e1 Cell Reports Medicine 5, 101587, June 18, 2024 OPEN ACCESS .. REAGENT or Article Title: Dual roles of CD11b + CD33 + HLA-DR -/low CD14 - myeloid-derived suppressor cells with a granulocytic morphology following allogeneic hematopoietic stem cell transplantation: from inflammation promoters to immune suppressors within 90 days. Article Snippet: Afterwards, erythrocytes were lysed using FACS lysing Solution (BD Biosciences). .. For intracellular staining, cells were fixed and permeabilized using BD Article Title: Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy Individuals. Article Snippet: We evaluated homologous neutralizing antibody (NtAb) and T‐cell responses after receipt of a JN.1‐adapted mRNA vaccine in a mixed population comprising healthy controls (HC) (n= 15), end‐stage chronic kidney disease (CKD) patients (n= 17), and allogeneic hematopoietic stem cell transplant recipients (allo‐HCT) (n= 13).. Most participants (42/45) were SARS‐CoV‐ 2‐experienced at the time of immunological testing.. JN.1‐spike‐binding NtAbs were measured with a vesicular stomatitis virus pseudotype‐based neutralization assay, whereas interferon (IFN)‐γ‐producing spike‐directed CD4 or CD8 T‐cell frequencies were enumerated using flow cytometry for intracellular staining. Incubation:Article Title: Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferons Article Snippet: Briefly, cells were incubated with LIVE/DEAD Fixable Green Dead Cell Stain Kit (ThermoFischer Scientific) and fluorochrome-conjugated antibodies directed against surface markers ( ) for 20 min at room temperature in the dark followed by 2 washes with flow cytometry buffer (PBS with 2 mM EDTA). .. Cells were then fixed and permeabilized using FACS Lysing solution and Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: Cells were then washed with PBS and stained with Live/Dead Fixable Blue Dead Cell Stain Kit (Invitrogen #L23105) according to the manufacturer’s instructions, washed with FACS buffer and incubated with 1:25 dilution anti-CD16 (BioLegend #302036) and 1:50 anti-CD20 (BD #563126) antibodies per sample. .. Cells were then washed twice, and residual red blood cells were lysed and all cells fixed in 100 ml BD lysis buffer (BD #349202), washed, and incubated with 200 ml BD Staining:Article Title: Innate lymphoid cells are activated in HFRS, and their function can be modulated by hantavirus-induced type I interferons Article Snippet: Briefly, cells were incubated with LIVE/DEAD Fixable Green Dead Cell Stain Kit (ThermoFischer Scientific) and fluorochrome-conjugated antibodies directed against surface markers ( ) for 20 min at room temperature in the dark followed by 2 washes with flow cytometry buffer (PBS with 2 mM EDTA). .. Cells were then fixed and permeabilized using FACS Lysing solution and Article Title: NKp30 and NKG2D contribute to natural killer recognition of HIV-infected cells Article Snippet: .. For the samples that require intracellular staining, cells were subsequently fixed with FACS Lyse (BD Biosciences), permeabilized with Article Title: IL-10 indirectly modulates functional activity of CD4 + CD28 null T-lymphocytes through LFA-3 and HLA class II inhibition. Article Snippet: Immunology Department, Hospital Universitario Central de Asturias, Oviedo, Spain Instituto de Investigaci on Sanitaria del Principado de Asturias (ISPA), Oviedo, Spain Instituto Universitario de Oncología del Principado de Asturias (IUOPA), Oviedo, Spain Hematology Department, Hospital Universitario Central de Asturias, Oviedo, Spain Section of Hemodynamics and Interventional Cardiology, Department of Cardiology, Hospital Universitario Central de Asturias, Oviedo, Spain Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Recombinant AMMO1 Snijder et al.28 N/A Recombinant CL40 with human constant regions Singh et al.30 N/A Recombinant CL59 with human constant regions Singh et al.30 N/A Recombinant 72A1 with human constant regions Singh et al.30 N/A Recombinant E1D1 with human constant regions Malhi et al.38 N/A Recombinant 770F7 Chen et al.27 N/A Recombinant 1D8 Zhu et al.29 N/A Recombinant 769B10 Bu et al.26 N/A AF488 anti-human CD3 clone SP34-2 BD Biosciences Cat#557705; RRID:AB_396814 AF488 anti-human CD4 clone OKT4 Biolegend Cat#317419; RRID:AB_571938 AF488 anti-human CD8 clone RPA-T8 BD Biosciences Cat#557704; RRID:AB_396813 AF488 anti-human CD14 clone M5E2 BD Biosciences Cat#561706; RRID: AB_10924601 BV421 anti-human CD20 clone 2H7 Biolegend Cat#302329; RRID: AB_10933088 anti-human CD28/ anti-CD49d BD Biosciences Cat#347690; RRID:AB_647457 BV570 anti-human CD16 Biolegend Cat#302036; RRID:AB_2632790 BV711 anti-human CD20 BD Biosciences Cat#563126; RRID:AB_2313579 BUV805 anti-human CD8 BD Biosciences Cat#612889; RRID:AB_2833078 BV480 anti-human CD4 BD Biosciences Cat#566148; RRID:AB_2739546 BUV395 anti-human CD3 BD Biosciences Cat#564117; RRID:AB_2738603 BB515 anti-human TNFa ThermoFisher Cat#11-7349-82; RRID: AB_465424 BV421 anti-human IFN-g BD Biosciences Cat#560371; RRID:AB_1645594 Allophycocyanin (APC)-anti-human IL-2 BioLegend Cat#500310; RRID:AB_315097 Goat anti-human IgG-HRP Southern Biotech Cat#2010-05; RRID:AB_2795564 Goat anti-human IgG Southern Biotech Cat#2040-01; RRID:AB_2795640 Bacterial and virus strains EBV B95.8/F Delecluse et al.53 N/A Rhesus Lymphocryptovirus strain LCL 8664 ATCC Cat#CRL-1805; RRID: CVCL_3464 Biological samples Rhesus macaque blood Washington National Primate Research Center N/A Chemicals, peptides, and recombinant proteins Sigma Adjuvant Systems Sigma Aldrich Cat#S6322 SMNP Silva et al.40 N/A NeutrAvidin Thermofisher Cat#31000 SureBlue Reserve TMB Microwell Peroxidase substrate SeraCare Cat#5120-0081 Totalseq APC-streptavidin BioLegend Cat#405283 Phycoerythrin (PE)- streptavidin BioLegend Cat#405203 eFluor 506 viability dye eBioscience Cat#65-0866-14 Rhesus Fc receptor inhibitor eBioscience Cat#14-9161-73 Overlapping 15 amino acid peptide pools spanning EBV gH and gL This study Synthesized by Mimotopes Brefeldin A Sigma-Aldrich Cat#B-7651 Live/Dead Fixable Blue Dead Cell Stain Kit Invitrogen Cat#L23105 BD lysis buffer BD Biosciences Cat#349202 (Continued on next page) e1 Cell Reports Medicine 5, 101587, June 18, 2024 OPEN ACCESS .. REAGENT or Article Title: Dual roles of CD11b + CD33 + HLA-DR -/low CD14 - myeloid-derived suppressor cells with a granulocytic morphology following allogeneic hematopoietic stem cell transplantation: from inflammation promoters to immune suppressors within 90 days. Article Snippet: Afterwards, erythrocytes were lysed using FACS lysing Solution (BD Biosciences). .. For intracellular staining, cells were fixed and permeabilized using BD Article Title: Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy Individuals. Article Snippet: We evaluated homologous neutralizing antibody (NtAb) and T‐cell responses after receipt of a JN.1‐adapted mRNA vaccine in a mixed population comprising healthy controls (HC) (n= 15), end‐stage chronic kidney disease (CKD) patients (n= 17), and allogeneic hematopoietic stem cell transplant recipients (allo‐HCT) (n= 13).. Most participants (42/45) were SARS‐CoV‐ 2‐experienced at the time of immunological testing.. JN.1‐spike‐binding NtAbs were measured with a vesicular stomatitis virus pseudotype‐based neutralization assay, whereas interferon (IFN)‐γ‐producing spike‐directed CD4 or CD8 T‐cell frequencies were enumerated using flow cytometry for intracellular staining. Lysis:Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: Cells were then washed with PBS and stained with Live/Dead Fixable Blue Dead Cell Stain Kit (Invitrogen #L23105) according to the manufacturer’s instructions, washed with FACS buffer and incubated with 1:25 dilution anti-CD16 (BioLegend #302036) and 1:50 anti-CD20 (BD #563126) antibodies per sample. .. Cells were then washed twice, and residual red blood cells were lysed and all cells fixed in 100 ml BD lysis buffer (BD #349202), washed, and incubated with 200 ml BD Transfection:Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Recombinant AMMO1 Snijder et al.28 N/A Recombinant CL40 with human constant regions Singh et al.30 N/A Recombinant CL59 with human constant regions Singh et al.30 N/A Recombinant 72A1 with human constant regions Singh et al.30 N/A Recombinant E1D1 with human constant regions Malhi et al.38 N/A Recombinant 770F7 Chen et al.27 N/A Recombinant 1D8 Zhu et al.29 N/A Recombinant 769B10 Bu et al.26 N/A AF488 anti-human CD3 clone SP34-2 BD Biosciences Cat#557705; RRID:AB_396814 AF488 anti-human CD4 clone OKT4 Biolegend Cat#317419; RRID:AB_571938 AF488 anti-human CD8 clone RPA-T8 BD Biosciences Cat#557704; RRID:AB_396813 AF488 anti-human CD14 clone M5E2 BD Biosciences Cat#561706; RRID: AB_10924601 BV421 anti-human CD20 clone 2H7 Biolegend Cat#302329; RRID: AB_10933088 anti-human CD28/ anti-CD49d BD Biosciences Cat#347690; RRID:AB_647457 BV570 anti-human CD16 Biolegend Cat#302036; RRID:AB_2632790 BV711 anti-human CD20 BD Biosciences Cat#563126; RRID:AB_2313579 BUV805 anti-human CD8 BD Biosciences Cat#612889; RRID:AB_2833078 BV480 anti-human CD4 BD Biosciences Cat#566148; RRID:AB_2739546 BUV395 anti-human CD3 BD Biosciences Cat#564117; RRID:AB_2738603 BB515 anti-human TNFa ThermoFisher Cat#11-7349-82; RRID: AB_465424 BV421 anti-human IFN-g BD Biosciences Cat#560371; RRID:AB_1645594 Allophycocyanin (APC)-anti-human IL-2 BioLegend Cat#500310; RRID:AB_315097 Goat anti-human IgG-HRP Southern Biotech Cat#2010-05; RRID:AB_2795564 Goat anti-human IgG Southern Biotech Cat#2040-01; RRID:AB_2795640 Bacterial and virus strains EBV B95.8/F Delecluse et al.53 N/A Rhesus Lymphocryptovirus strain LCL 8664 ATCC Cat#CRL-1805; RRID: CVCL_3464 Biological samples Rhesus macaque blood Washington National Primate Research Center N/A Chemicals, peptides, and recombinant proteins Sigma Adjuvant Systems Sigma Aldrich Cat#S6322 SMNP Silva et al.40 N/A NeutrAvidin Thermofisher Cat#31000 SureBlue Reserve TMB Microwell Peroxidase substrate SeraCare Cat#5120-0081 Totalseq APC-streptavidin BioLegend Cat#405283 Phycoerythrin (PE)- streptavidin BioLegend Cat#405203 eFluor 506 viability dye eBioscience Cat#65-0866-14 Rhesus Fc receptor inhibitor eBioscience Cat#14-9161-73 Overlapping 15 amino acid peptide pools spanning EBV gH and gL This study Synthesized by Mimotopes Brefeldin A Sigma-Aldrich Cat#B-7651 Live/Dead Fixable Blue Dead Cell Stain Kit Invitrogen Cat#L23105 BD lysis buffer BD Biosciences Cat#349202 (Continued on next page) e1 Cell Reports Medicine 5, 101587, June 18, 2024 OPEN ACCESS .. REAGENT or Multiplex Assay:Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Recombinant AMMO1 Snijder et al.28 N/A Recombinant CL40 with human constant regions Singh et al.30 N/A Recombinant CL59 with human constant regions Singh et al.30 N/A Recombinant 72A1 with human constant regions Singh et al.30 N/A Recombinant E1D1 with human constant regions Malhi et al.38 N/A Recombinant 770F7 Chen et al.27 N/A Recombinant 1D8 Zhu et al.29 N/A Recombinant 769B10 Bu et al.26 N/A AF488 anti-human CD3 clone SP34-2 BD Biosciences Cat#557705; RRID:AB_396814 AF488 anti-human CD4 clone OKT4 Biolegend Cat#317419; RRID:AB_571938 AF488 anti-human CD8 clone RPA-T8 BD Biosciences Cat#557704; RRID:AB_396813 AF488 anti-human CD14 clone M5E2 BD Biosciences Cat#561706; RRID: AB_10924601 BV421 anti-human CD20 clone 2H7 Biolegend Cat#302329; RRID: AB_10933088 anti-human CD28/ anti-CD49d BD Biosciences Cat#347690; RRID:AB_647457 BV570 anti-human CD16 Biolegend Cat#302036; RRID:AB_2632790 BV711 anti-human CD20 BD Biosciences Cat#563126; RRID:AB_2313579 BUV805 anti-human CD8 BD Biosciences Cat#612889; RRID:AB_2833078 BV480 anti-human CD4 BD Biosciences Cat#566148; RRID:AB_2739546 BUV395 anti-human CD3 BD Biosciences Cat#564117; RRID:AB_2738603 BB515 anti-human TNFa ThermoFisher Cat#11-7349-82; RRID: AB_465424 BV421 anti-human IFN-g BD Biosciences Cat#560371; RRID:AB_1645594 Allophycocyanin (APC)-anti-human IL-2 BioLegend Cat#500310; RRID:AB_315097 Goat anti-human IgG-HRP Southern Biotech Cat#2010-05; RRID:AB_2795564 Goat anti-human IgG Southern Biotech Cat#2040-01; RRID:AB_2795640 Bacterial and virus strains EBV B95.8/F Delecluse et al.53 N/A Rhesus Lymphocryptovirus strain LCL 8664 ATCC Cat#CRL-1805; RRID: CVCL_3464 Biological samples Rhesus macaque blood Washington National Primate Research Center N/A Chemicals, peptides, and recombinant proteins Sigma Adjuvant Systems Sigma Aldrich Cat#S6322 SMNP Silva et al.40 N/A NeutrAvidin Thermofisher Cat#31000 SureBlue Reserve TMB Microwell Peroxidase substrate SeraCare Cat#5120-0081 Totalseq APC-streptavidin BioLegend Cat#405283 Phycoerythrin (PE)- streptavidin BioLegend Cat#405203 eFluor 506 viability dye eBioscience Cat#65-0866-14 Rhesus Fc receptor inhibitor eBioscience Cat#14-9161-73 Overlapping 15 amino acid peptide pools spanning EBV gH and gL This study Synthesized by Mimotopes Brefeldin A Sigma-Aldrich Cat#B-7651 Live/Dead Fixable Blue Dead Cell Stain Kit Invitrogen Cat#L23105 BD lysis buffer BD Biosciences Cat#349202 (Continued on next page) e1 Cell Reports Medicine 5, 101587, June 18, 2024 OPEN ACCESS .. REAGENT or Polymerase Chain Reaction:Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Recombinant AMMO1 Snijder et al.28 N/A Recombinant CL40 with human constant regions Singh et al.30 N/A Recombinant CL59 with human constant regions Singh et al.30 N/A Recombinant 72A1 with human constant regions Singh et al.30 N/A Recombinant E1D1 with human constant regions Malhi et al.38 N/A Recombinant 770F7 Chen et al.27 N/A Recombinant 1D8 Zhu et al.29 N/A Recombinant 769B10 Bu et al.26 N/A AF488 anti-human CD3 clone SP34-2 BD Biosciences Cat#557705; RRID:AB_396814 AF488 anti-human CD4 clone OKT4 Biolegend Cat#317419; RRID:AB_571938 AF488 anti-human CD8 clone RPA-T8 BD Biosciences Cat#557704; RRID:AB_396813 AF488 anti-human CD14 clone M5E2 BD Biosciences Cat#561706; RRID: AB_10924601 BV421 anti-human CD20 clone 2H7 Biolegend Cat#302329; RRID: AB_10933088 anti-human CD28/ anti-CD49d BD Biosciences Cat#347690; RRID:AB_647457 BV570 anti-human CD16 Biolegend Cat#302036; RRID:AB_2632790 BV711 anti-human CD20 BD Biosciences Cat#563126; RRID:AB_2313579 BUV805 anti-human CD8 BD Biosciences Cat#612889; RRID:AB_2833078 BV480 anti-human CD4 BD Biosciences Cat#566148; RRID:AB_2739546 BUV395 anti-human CD3 BD Biosciences Cat#564117; RRID:AB_2738603 BB515 anti-human TNFa ThermoFisher Cat#11-7349-82; RRID: AB_465424 BV421 anti-human IFN-g BD Biosciences Cat#560371; RRID:AB_1645594 Allophycocyanin (APC)-anti-human IL-2 BioLegend Cat#500310; RRID:AB_315097 Goat anti-human IgG-HRP Southern Biotech Cat#2010-05; RRID:AB_2795564 Goat anti-human IgG Southern Biotech Cat#2040-01; RRID:AB_2795640 Bacterial and virus strains EBV B95.8/F Delecluse et al.53 N/A Rhesus Lymphocryptovirus strain LCL 8664 ATCC Cat#CRL-1805; RRID: CVCL_3464 Biological samples Rhesus macaque blood Washington National Primate Research Center N/A Chemicals, peptides, and recombinant proteins Sigma Adjuvant Systems Sigma Aldrich Cat#S6322 SMNP Silva et al.40 N/A NeutrAvidin Thermofisher Cat#31000 SureBlue Reserve TMB Microwell Peroxidase substrate SeraCare Cat#5120-0081 Totalseq APC-streptavidin BioLegend Cat#405283 Phycoerythrin (PE)- streptavidin BioLegend Cat#405203 eFluor 506 viability dye eBioscience Cat#65-0866-14 Rhesus Fc receptor inhibitor eBioscience Cat#14-9161-73 Overlapping 15 amino acid peptide pools spanning EBV gH and gL This study Synthesized by Mimotopes Brefeldin A Sigma-Aldrich Cat#B-7651 Live/Dead Fixable Blue Dead Cell Stain Kit Invitrogen Cat#L23105 BD lysis buffer BD Biosciences Cat#349202 (Continued on next page) e1 Cell Reports Medicine 5, 101587, June 18, 2024 OPEN ACCESS .. REAGENT or Luciferase:Article Title: Vaccination with nanoparticles displaying gH/gL from Epstein-Barr virus elicits limited cross-protection against rhesus lymphocryptovirus. Article Snippet: REAGENT or RESOURCE SOURCE IDENTIFIER Antibodies Recombinant AMMO1 Snijder et al.28 N/A Recombinant CL40 with human constant regions Singh et al.30 N/A Recombinant CL59 with human constant regions Singh et al.30 N/A Recombinant 72A1 with human constant regions Singh et al.30 N/A Recombinant E1D1 with human constant regions Malhi et al.38 N/A Recombinant 770F7 Chen et al.27 N/A Recombinant 1D8 Zhu et al.29 N/A Recombinant 769B10 Bu et al.26 N/A AF488 anti-human CD3 clone SP34-2 BD Biosciences Cat#557705; RRID:AB_396814 AF488 anti-human CD4 clone OKT4 Biolegend Cat#317419; RRID:AB_571938 AF488 anti-human CD8 clone RPA-T8 BD Biosciences Cat#557704; RRID:AB_396813 AF488 anti-human CD14 clone M5E2 BD Biosciences Cat#561706; RRID: AB_10924601 BV421 anti-human CD20 clone 2H7 Biolegend Cat#302329; RRID: AB_10933088 anti-human CD28/ anti-CD49d BD Biosciences Cat#347690; RRID:AB_647457 BV570 anti-human CD16 Biolegend Cat#302036; RRID:AB_2632790 BV711 anti-human CD20 BD Biosciences Cat#563126; RRID:AB_2313579 BUV805 anti-human CD8 BD Biosciences Cat#612889; RRID:AB_2833078 BV480 anti-human CD4 BD Biosciences Cat#566148; RRID:AB_2739546 BUV395 anti-human CD3 BD Biosciences Cat#564117; RRID:AB_2738603 BB515 anti-human TNFa ThermoFisher Cat#11-7349-82; RRID: AB_465424 BV421 anti-human IFN-g BD Biosciences Cat#560371; RRID:AB_1645594 Allophycocyanin (APC)-anti-human IL-2 BioLegend Cat#500310; RRID:AB_315097 Goat anti-human IgG-HRP Southern Biotech Cat#2010-05; RRID:AB_2795564 Goat anti-human IgG Southern Biotech Cat#2040-01; RRID:AB_2795640 Bacterial and virus strains EBV B95.8/F Delecluse et al.53 N/A Rhesus Lymphocryptovirus strain LCL 8664 ATCC Cat#CRL-1805; RRID: CVCL_3464 Biological samples Rhesus macaque blood Washington National Primate Research Center N/A Chemicals, peptides, and recombinant proteins Sigma Adjuvant Systems Sigma Aldrich Cat#S6322 SMNP Silva et al.40 N/A NeutrAvidin Thermofisher Cat#31000 SureBlue Reserve TMB Microwell Peroxidase substrate SeraCare Cat#5120-0081 Totalseq APC-streptavidin BioLegend Cat#405283 Phycoerythrin (PE)- streptavidin BioLegend Cat#405203 eFluor 506 viability dye eBioscience Cat#65-0866-14 Rhesus Fc receptor inhibitor eBioscience Cat#14-9161-73 Overlapping 15 amino acid peptide pools spanning EBV gH and gL This study Synthesized by Mimotopes Brefeldin A Sigma-Aldrich Cat#B-7651 Live/Dead Fixable Blue Dead Cell Stain Kit Invitrogen Cat#L23105 BD lysis buffer BD Biosciences Cat#349202 (Continued on next page) e1 Cell Reports Medicine 5, 101587, June 18, 2024 OPEN ACCESS .. REAGENT or Labeling:Article Title: Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy Individuals. Article Snippet: We evaluated homologous neutralizing antibody (NtAb) and T‐cell responses after receipt of a JN.1‐adapted mRNA vaccine in a mixed population comprising healthy controls (HC) (n= 15), end‐stage chronic kidney disease (CKD) patients (n= 17), and allogeneic hematopoietic stem cell transplant recipients (allo‐HCT) (n= 13).. Most participants (42/45) were SARS‐CoV‐ 2‐experienced at the time of immunological testing.. JN.1‐spike‐binding NtAbs were measured with a vesicular stomatitis virus pseudotype‐based neutralization assay, whereas interferon (IFN)‐γ‐producing spike‐directed CD4 or CD8 T‐cell frequencies were enumerated using flow cytometry for intracellular staining. Bioprocessing:Article Title: Neutralizing Antibody and T-Cell Spike Targeted Responses Following Receipt of a Monovalent Omicron JN.1-Adapted mRNA COVID-19 Vaccine in Immunosuppressed and Healthy Individuals. Article Snippet: We evaluated homologous neutralizing antibody (NtAb) and T‐cell responses after receipt of a JN.1‐adapted mRNA vaccine in a mixed population comprising healthy controls (HC) (n= 15), end‐stage chronic kidney disease (CKD) patients (n= 17), and allogeneic hematopoietic stem cell transplant recipients (allo‐HCT) (n= 13).. Most participants (42/45) were SARS‐CoV‐ 2‐experienced at the time of immunological testing.. JN.1‐spike‐binding NtAbs were measured with a vesicular stomatitis virus pseudotype‐based neutralization assay, whereas interferon (IFN)‐γ‐producing spike‐directed CD4 or CD8 T‐cell frequencies were enumerated using flow cytometry for intracellular staining. |